About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Penn Medicine's 2021 Updates in Care of the Hematologic Malignancies Patient
COVID-19
New Therapies and Current Patient Management of Lymphomas
Update on Patient Care Treatment Strategies in Leukemia
Controversies and Update for Patient Care in Multiple Myeloma
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
J
Overview of New Therapies and Current Management of CLL, SLL & Richter’s Transformation
By
Penn Medicine's 2021 Updates in Care of the Hematologic Malignancies Patient
FEATURING
James Gerson
By
Penn Medicine's 2021 Updates in Care of the Hematologic Malignancies Patient
FEATURING
James Gerson
133 views
July 15, 2021
0 Comments
Login to view comments.
Click here to Login
Featured Video
24:08
Indy Hematology Review
Evaluation, Diagnosis, Prognostication, and Emerging Therapies for M…
Feat.
A. Tefferi
Featured Video
08:18
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "Treatment Strategies for Hematocrit Control…
Feat.
A. Zhou
New Therapies and Current Patient Management of Lymphomas
16:47
Penn Medicine's 2021 Updates in Care of the Hematologic Malignancies Patient
Overview of New Therapies and Current Management of CLL, SLL & R…
Feat.
J. Gerson
08:09
Penn Medicine's 2021 Updates in Care of the Hematologic Malignancies Patient
Updates on MCL: Ibrutinib + Ven, Len + Rituximab, 1L Sequential Immu…
Feat.
J. Gerson
07:39
Penn Medicine's 2021 Updates in Care of the Hematologic Malignancies Patient
UPenn 2021 Updates on PTCL: Does the Addition of Romidepsin to CHOP …
Feat.
J. Svoboda
07:09
Penn Medicine's 2021 Updates in Care of the Hematologic Malignancies Patient
Older Adults With cHL: Considering Brentuximab Vedotin Mono & Co…
Feat.
J. Svoboda
10:50
Penn Medicine's 2021 Updates in Care of the Hematologic Malignancies Patient
ASH Updates on R/R cHL: How to Consider Pembro-GVH? What Is the Role…
Feat.
J. Svoboda
17:46
Penn Medicine's 2021 Updates in Care of the Hematologic Malignancies Patient
UPenn Expert Discussion on Lymphoma: Efficacy of Acalabrutinib for S…
Feat.
S. Schuster,
J. Gerson,
J. Svoboda,
E. Chong,
S. Nasta,
D. Beach,
G. Hanna
10:41
Penn Medicine's 2021 Updates in Care of the Hematologic Malignancies Patient
ASH Updates on Large Cell & Aggressive Lymphomas: Antibody Lonca…
Feat.
S. Nasta
09:00
Penn Medicine's 2021 Updates in Care of the Hematologic Malignancies Patient
ASH Updates on Lymphomas: 1L (Axi-Cel) in High-Risk DLBCL, Safety, D…
Feat.
S. Nasta
09:41
Penn Medicine's 2021 Updates in Care of the Hematologic Malignancies Patient
UPenn ASH Highlights on PI3Ki & BTKi for R/R MZL: How Effective …
Feat.
E. Chong
10:32
Penn Medicine's 2021 Updates in Care of the Hematologic Malignancies Patient
UPenn ASH Highlights on CAR-T & Bispecific Antibodies for iNHL: …
Feat.
E. Chong